P

Platelet BioGenesis

8 employees

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug discovery
Life Science
platelets
biotechnology
Product Research
Ediscovery

Date founded

2014

Funding rounds raised

Total raised

$76M

from 12 investors over 12 rounds

P

Platelet BioGenesis raised $76M on November 4, 2021

Investors: Oxford Finance LLC, K2 HealthVentures and Qiming Venture Partners

P

Platelet BioGenesis raised $2.3M on December 16, 2019

Investors: Medical Technology Enterprise Consortium

P

Platelet BioGenesis raised $26M on September 9, 2019

Investors: Qiming Venture Partners

P

Platelet BioGenesis raised undisclosed on May 31, 2019

Investors: EQx Fund

P

Platelet BioGenesis raised $3.5M on June 28, 2018

Investors: united-states-department-of-defense

P

Platelet BioGenesis raised $200K on June 28, 2017

Investors: Massachusetts Life Sciences Center

P

Platelet BioGenesis raised $10M on June 8, 2017

Investors: Vivo Capital, eCoast Angel Network and Qiming Venture Partners

P

Platelet BioGenesis raised $600K on January 14, 2017

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ